Enbridge Inc
ENB
Shopify Inc
SHOP
The Toronto-Dominion Bank
TD
4
BCE Inc
BCE
5
Celestica Inc
CLS
CA Stock MarketDetailed Quotes
MSCL Satellos Bioscience Inc
- 0.640
- +0.010+1.59%
15min DelayMarket Closed Apr 29 16:00 ET
106.12MMarket Cap2.56P/E (TTM)
0.660High0.630Low121.10KVolume0.630Open0.630Pre Close78.57KTurnover1.32052wk High0.09%Turnover Ratio165.82MShares0.38052wk Low0.25EPS TTM88.50MFloat Cap2.500Historical High2.56P/E (Static)138.28MShs Float0.020Historical Low0.25EPS LYR4.76%Amplitude--Dividend TTM1.56P/B1Lot Size--Div YieldTTM
Satellos Bioscience Inc Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 79.84%27.81M | 25.05%7.81M | 12.79%5.06M | 118.20%6.68M | 395.50%8.26M | 83.47%15.46M | 176.83%6.25M | 144.05%4.49M | 39.04%3.06M | -21.07%1.67M |
| Selling and administrative expenses | 22.28%7.41M | -17.81%2.03M | 8.08%1.69M | 15.60%1.62M | 228.80%2.08M | 53.01%6.06M | 117.05%2.47M | 111.67%1.56M | 49.45%1.4M | -26.01%632K |
| -General and administrative expense | 22.28%7.41M | -17.81%2.03M | 8.08%1.69M | 15.60%1.62M | 228.80%2.08M | 53.01%6.06M | 117.05%2.47M | 111.67%1.56M | 49.45%1.4M | -26.01%632K |
| Research and development costs | 122.33%19.6M | 54.28%5.53M | 19.35%3.26M | 211.17%4.87M | 536.44%5.94M | 136.13%8.82M | 251.82%3.59M | 204.45%2.73M | 154.20%1.57M | 35.72%933K |
| Depreciation amortization depletion | 185.71%20K | 500.00%12K | 50.00%3K | 200.00%3K | 100.00%2K | -97.92%7K | -83.33%2K | -98.18%2K | -99.07%1K | -99.06%1K |
| -Depreciation and amortization | 185.71%20K | 500.00%12K | 50.00%3K | 200.00%3K | 100.00%2K | -97.92%7K | -83.33%2K | -98.18%2K | -99.07%1K | -99.06%1K |
| Other operating expenses | 33.79%776K | 25.65%240K | -42.71%110K | 93.81%188K | 137.00%237K | 46.10%580K | 117.05%191K | 104.26%192K | -82.12%97K | -78.37%100K |
| Operating profit | -79.84%-27.81M | -25.05%-7.81M | -12.79%-5.06M | -118.20%-6.68M | -395.50%-8.26M | -83.47%-15.46M | -176.83%-6.25M | -144.05%-4.49M | -39.04%-3.06M | 21.07%-1.67M |
| Net non-operating interest income (expenses) | 18.60%1.37M | -51.87%257K | -35.39%314K | 159.42%358K | 44,300.00%442K | 1,734.92%1.16M | 853.57%534K | 24,200.00%486K | 6,579.57%138K | -132.97%-1K |
| Non-operating interest income | 2.85%1.37M | -51.87%257K | -42.07%314K | 43.20%358K | 6,214.29%442K | 2,015.87%1.33M | 853.57%534K | 27,000.00%542K | 12,000.68%250K | 130.79%7K |
| Non-operating interest expense | --0 | --0 | --0 | --0 | --0 | --177K | --0 | --56K | --112K | --8K |
| Other net income (expenses) | -5.06%-1.66M | 276.61%1.45M | -1,104.67%-4.3M | 123.91%285K | 90,300.00%904K | 46.41%-1.58M | 71.34%-821K | 790.32%428K | -3,129.21%-1.19M | 112.28%1K |
| Gain on sale of security | 298.88%2.3M | 276.61%1.45M | -139.70%-339K | 123.91%285K | 90,300.00%904K | -1,625.37%-1.16M | -4,205.00%-821K | 1,477.42%854K | -4,229.19%-1.19M | -64.75%1K |
| Special income (charges) | -829.81%-3.96M | --0 | -829.81%-3.96M | ---- | ---- | 85.23%-426K | --0 | ---426K | ---- | ---- |
| -Less:Impairment of capital assets | --3.96M | --0 | --3.96M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | --426K | --0 | --426K | ---- | ---- |
| Income before tax | -76.85%-28.1M | 6.56%-6.11M | -153.16%-9.05M | -46.68%-6.04M | -314.71%-6.91M | -40.40%-15.89M | -29.00%-6.54M | -88.20%-3.57M | -84.01%-4.12M | 21.26%-1.67M |
| Income tax | 0 | 0 | ||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -76.85%-28.1M | 6.56%-6.11M | -153.16%-9.05M | -46.68%-6.04M | -314.71%-6.91M | -40.34%-15.89M | -28.87%-6.54M | -88.20%-3.57M | -84.01%-4.12M | 21.26%-1.67M |
| Net income continuous operations | -76.85%-28.1M | 6.56%-6.11M | -153.16%-9.05M | -46.68%-6.04M | -314.71%-6.91M | -40.34%-15.89M | -28.87%-6.54M | -88.20%-3.57M | -84.01%-4.12M | 21.26%-1.67M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -76.85%-28.1M | 6.56%-6.11M | -153.16%-9.05M | -46.68%-6.04M | -314.71%-6.91M | -40.34%-15.89M | -28.87%-6.54M | -88.20%-3.57M | -84.01%-4.12M | 21.26%-1.67M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -76.85%-28.1M | 6.56%-6.11M | -153.16%-9.05M | -46.68%-6.04M | -314.71%-6.91M | -40.34%-15.89M | -28.87%-6.54M | -88.20%-3.57M | -84.01%-4.12M | 21.26%-1.67M |
| Diluted earnings per share | 238.89%0.25 | 833.33%0.44 | -166.67%-0.08 | 0.00%-0.05 | -50.00%-0.06 | 43.75%-0.18 | 53.85%-0.06 | 40.00%-0.03 | 28.57%-0.05 | 33.33%-0.04 |
| Basic earnings per share | 238.89%0.25 | 38.63%-0.0368 | -166.67%-0.08 | 0.00%-0.05 | -50.00%-0.06 | 43.75%-0.18 | 53.85%-0.06 | 40.00%-0.03 | 28.57%-0.05 | 33.33%-0.04 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.